AIRNA

Company

Last deal

$60.M

Amount

Series A

Stage

31.07.2024

Date

all rounds

$90.M

Total amount

General

About Company

AIRNA is a biotech company developing RNA editing therapies for rare and common ailments.

Industry

Sector :

Subsector :

founded date

2021

Number of employees

11-50

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals suffering from both rare and common ailments.

Contacts

location

Cambridge, MA, USA

Phone number

+16503536297

Website URL

https://airna.com

Social url